Galderma Group AG

Galderma Group AG is a leading global dermatology company headquartered in Zug, Switzerland, founded in 1981. The company operates across three core business segments: injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio encompasses flagship brands including Dysport and Azzalure for aesthetic treatments, Restylane and Sculptra for dermal fillers and biostimulators, and consumer care products like Cetaphil and Differin for acne and skincare. The company also offers prescription medications addressing conditions such as atopic dermatitis, psoriasis, and prurigo nodularis under brands like Soolantra, Epiduo, and Nemluvio. Galderma maintains a global presence through manufacturing facilities in France, Canada, Sweden, and Brazil, combined with research and development operations across multiple countries. The company serves healthcare professionals and consumers through more than 100 countries, positioning itself as the world's largest independent dermatology company dedicated exclusively to skin health and innovation.